BACKGROUND
According to the data from The Global Cancer Observatory (GCO), cancer is now one of the most serious diseases worldwide with around 20 million new cases and nearly 9.6 million deaths. In addition to a wide range of genetic and epigenetic alterations, components of the tumor microenvironment have a major impact on tumor progression. The tumor microenvironment (TME) is the environment around tumor, including the surrounding blood vessels, immune cells, fibroblasts, signaling molecules and the extracellular matrix (ECM). These cellular and non-cellular components of TME can reprogram the processes of tumor occurrence and development by regulating different cascade signaling pathways. Therefore, understanding the underlying cellular and molecular mechanisms governing these interactions can be used as a novel strategy to disrupt cancer development and contribute to the development of efficient and safe therapeutic strategies to fight cancer.
Nowadays, the TME becomes a hot area for antibody drug development and cancer treatment. ACROBiosystems have developed a series of TME related targets, such as TGF-β, Notch, etc., helping for cancer treatment and fast your R&D procedure.
A-Z
